Showing results (431-440 of 533) with videos related to

Sort By:
Pageof 54
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|February 28, 2009
Defining refractory migraine: results of the RHSIS Survey of American Headache Society membersElliott A Schulman, B Lee Peterlin, Alvin E Lake, et al.
Pain and Therapy|February 1, 2025
Impact of Headache and Over-the-Counter Treatment on Pain and Functional and Cognitive Parameters: A Real-World Study across Three GeographiesPeter J Goadsby, Andreas Straube, Mamoru Shibata, et al.
The Journal of Headache and Pain|April 2, 2021
21st century headache: mapping new territoryPeter J Goadsby, Michel Lantéri-Minet, Martin C Michel, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialHong Sun, David W Dodick, Stephen Silberstein, et al.
International Journal of Cancer|December 15, 2010
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphateSarah Jane Lunt, Simon Akerman, Sally A Hill, et al.
Brain Sciences|October 28, 2023
Mental Imagery in Dreams of Congenitally Blind PeopleJungwoo Kang, Rita Bertani, Kausar Raheel, et al.
Headache|February 1, 2008
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan databaseDavid W Dodick, Richard B Lipton, Peter J Goadsby, et al.
Neurology|June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time pointsMarcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
Pageof 54